Remynd

This study tested an oral medication called REM0046127 in people with mild to moderate Alzheimer's disease. It aimed to see if the drug could affect certain brain fluid markers and brain wave patterns, and to check its safety. The trial was terminated early and only enrolled 14 o…

This was an early-stage study to check the safety of a new oral medicine called REM0045392, which is being developed to treat Alzheimer's disease. It involved 19 healthy men and older adults who took single or multiple doses over 14 days. The main goal was to see how the body pro…